Cargando…

Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway

Glioma originated from excessively proliferative and highly invaded glial cells is a common intracranial malignant tumor with poor prognosis. Resistance to temozolomide (TMZ) is a clinical challenge in glioma treatment due to the fact that chemoresistance remains a main obstacle in the improvement o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Tingting, Chen, Rongrong, Zhou, Yu, Zhang, Juan, Zhang, Zhongqin, Wei, Hui, Xu, Yan, Wang, Yulan, Zhang, Yinlan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276020/ https://www.ncbi.nlm.nih.gov/pubmed/35505656 http://dx.doi.org/10.1080/21655979.2022.2070963

Ejemplares similares

Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction
por: Zhong, Weilong, et al.
Publicado: (2018)

TMZ-BioShuttle – a reformulated Temozolomide
por: Waldeck, Waldemar, et al.
Publicado: (2008)

OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth()()
por: Towner, Rheal A., et al.
Publicado: (2018)

Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells
por: Harder, Bryan G., et al.
Publicado: (2019)

Ivermectin represses Wnt/β-catenin signaling by binding to TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases
por: Yonezawa, Honami, et al.
Publicado: (2022)

Radiosensitization of Glioma Cells by Temozolomide (TMZ): A Colony Formation Assay
por: Babaloui, Somayyeh, et al.
Publicado: (2022)

CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells
Publicado: (1995)

Salvianolic acid B attenuates membranous nephropathy by activating renal autophagy via microRNA-145-5p/phosphatidylinositol 3-kinase/AKT pathway
por: Chen, Junqi, et al.
Publicado: (2022)

Phosphatidylinositol 3 kinase modulation of trophoblast cell differentiation
por: Kent, Lindsey N, et al.
Publicado: (2010)

Architecture and dynamics of the autophagic phosphatidylinositol 3-kinase complex
por: Baskaran, Sulochanadevi, et al.
Publicado: (2014)

Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome
por: Cohen, Jeffrey I.
Publicado: (2018)

Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia
por: Goncalves, Marcus D., et al.
Publicado: (2022)

Salvianolic acid B ameliorates psoriatic changes in imiquimod-induced psoriasis on BALB/c mice by inhibiting inflammatory and keratin markers via altering phosphatidylinositol-3-kinase/protein kinase B signaling pathway
por: Wang, Shoufan, et al.
Publicado: (2020)

Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons
por: Philpott, Karen L., et al.
Publicado: (1997)

Regulation of the Target of Rapamycin and Other Phosphatidylinositol 3-Kinase-Related Kinases by Membrane Targeting
por: De Cicco, Maristella, et al.
Publicado: (2015)

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2013)

Structural basis of phosphatidylinositol 3-kinase C2α function
por: Lo, Wen-Ting, et al.
Publicado: (2022)

Phosphatidylinositol 3-Kinase Is a Negative Regulator of Cellular Differentiation
por: Ptasznik, Andrzej, et al.
Publicado: (1997)

Multiple Phosphatidylinositol 3-Kinases Regulate Vaccinia Virus Morphogenesis
por: McNulty, Shannon, et al.
Publicado: (2010)

The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011)

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment
por: Brana, Irene, et al.
Publicado: (2012)

Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
por: Zhao, Wennan, et al.
Publicado: (2017)

Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking
por: Yoshioka, Kazuaki
Publicado: (2021)

A novel series of phenolic temozolomide (TMZ) esters with 4 to 5-fold increased potency, compared to TMZ, against glioma cells irrespective of MGMT expression
por: Shervington, Leroy, et al.
Publicado: (2020)

Inhibitory Activity of Flavonoids against Class I Phosphatidylinositol 3-Kinase Isoforms
por: Kong, Dexin, et al.
Publicado: (2011)

SUN-932 Successful Response of Temozolomide (TMZ) in two Patients with Metastatic Pheochromocytoma/Paragangliomas (PPGLs)
por: de Almeida, Tobias Skrebsky, et al.
Publicado: (2020)

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
por: Knowles, Margaret A., et al.
Publicado: (2009)

Inhibitors of Phosphatidylinositol 3′-Kinases Promote Mitotic Cell Death in HeLa Cells
por: Hou, Heli, et al.
Publicado: (2012)

Palmitic acid declines glucose uptake in HepG2 cells via modulating phosphoglucomutase 1 to repress phosphatidylinositol 3 kinase/protein kinase B and JNK pathways via inducing microRNA-124-3p
por: ZHANG, LingHui, et al.
Publicado: (2022)

Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases
por: Adamo, Barbara, et al.
Publicado: (2011)

Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma
por: Fang, Xiaosheng, et al.
Publicado: (2013)

Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies
por: Castillo, Jorge J, et al.
Publicado: (2014)

Involvement of Phosphatidylinositol 3-kinase in the regulation of proline catabolism in Arabidopsis thaliana
por: Leprince, Anne-Sophie, et al.
Publicado: (2015)

Phosphatidylinositol 3-Kinase γ Is Required for the Development of Experimental Cerebral Malaria
por: Lacerda-Queiroz, Norinne, et al.
Publicado: (2015)

Synthesis of Pelorol and Its Analogs and Their Inhibitory Effects on Phosphatidylinositol 3-Kinase
por: Luo, Yongjie, et al.
Publicado: (2016)

Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
por: Lo, Wen-Ting, et al.
Publicado: (2022)

Mucocutaneous drug reaction after treatment with Phosphatidylinositol-3-kinase inhibitor
por: Starzyk, Tory, et al.
Publicado: (2021)

Phosphatidylinositol 3‐Kinase δ Deficiency Protects From Antimyeloperoxidase Vasculitis
por: Flórez‐Barrós, Fernanda, et al.
Publicado: (2022)

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis
por: Tang, Jun-Hai, et al.
Publicado: (2019)

Phosphatidylinositol Kinases and Phosphatases in Entamoeba histolytica
por: Nakada-Tsukui, Kumiko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k492pqufs8qpgcpmf3jsp8hqk3